SCHEMBL22574016

SCHEMBL22574016

Cc1cccc(NC(=O)c2cnc(-c3ccco3)nc2N)n1

nearest known ligand 0.58

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ ADORA3 P0DMS8 2/20 0.58
▸ ADORA2A P29274 2/20 0.58
▸ ADORA2B P29275 2/20 0.58
▸ ADORA1 P30542 2/20 0.58
▸ HSD17B10 Q99714 3/20 0.56
▸ TSHR P16473 2/20 0.56
▸ ALDH1A1 P00352 2/20 0.56
▸ HPGD P15428 2/20 0.56
▸ KDM4E B2RXH2 1/20 0.56
▸ ALOX15 P16050 1/20 0.56
▸ SMN1; SMN2 Q16637 1/20 0.55
▸ GRM5 P41594 4/20 0.53
▸ GLA P06280 1/20 0.48
▸ NPSR1 Q6W5P4 1/20 0.48
▸ KMT2A Q03164 3/20 0.47
▸ ATM Q13315 1/20 0.46
▸ SORT1 Q99523 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22573626 0.84 ADORA3 (0.58) ADORA3ADORA2AADORA2BADORA1HSD17B10
SCHEMBL22573609 0.84 ADORA2A (0.66) ADORA3ADORA2AADORA2BADORA1HSD17B10
SCHEMBL22573343 0.83 TSHR (0.58) ADORA3ADORA2AADORA2BADORA1TSHR
SCHEMBL22573501 0.83 ADORA3 (0.60) ADORA3ADORA2AADORA2BADORA1HSD17B10
SCHEMBL22573702 0.83 ADORA2A (0.68) ADORA3ADORA2AADORA2BADORA1
SCHEMBL22573552 0.82 ADORA2A (0.66) ADORA3ADORA2AADORA2BADORA1HSD17B10
SCHEMBL22573408 0.82 ADORA3 (0.60) ADORA3ADORA2AADORA2BADORA1HSD17B10
SCHEMBL22573570 0.81 GRM5 (0.61) HSD17B10ALDH1A1HPGDSMN1; SMN2GRM5
SCHEMBL22573464 0.81 ADORA2A (0.57) ADORA3ADORA2AADORA2BADORA1HSD17B10
SCHEMBL22573768 0.81 ADORA2A (0.65) ADORA3ADORA2AADORA2BADORA1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3728236-A1 PYRIMIDINE DERIVATIVES AND THEIR USE USE FOR THE TREATMENT OF CANCER Adorx therapeutics Limited (GB) 2020-10-28 — — EP claimed
Send feedback